Emergency Contraception and Heart Conditions: Safety Guide for Women with Cardiovascular Disease

Emergency contraception (EC)—levonorgestrel (Plan B) or ulipristal acetate (ella)—is generally safe, but women with heart conditions need individualized assessment.

Key Considerations

  • Thrombotic risk: Progestin-only EC (levonorgestrel) has minimal thrombotic risk vs. combined estrogen-progestin pills. Ulipristal's risk is theoretical but low with single dose.
  • Drug interactions: Enzyme inducers (rifampin, certain anticonvulsants, St. John's wort) reduce EC efficacy. Some cardiac drugs (e.g., beta-blockers, ACE inhibitors) don't interact significantly.
  • Hemodynamic effects: Nausea/vomiting from EC may cause transient hypotension or tachycardia—monitor if autonomic instability exists.
  • Specific conditions:
    • Aortic stenosis: Avoid vasodilatory effects; monitor for syncope.
    • Arrhythmias: Single-dose progestin unlikely to provoke, but electrolyte shifts from vomiting could.
    • Hypertension: No acute BP elevation expected.
    • Anticoagulation: No direct interaction, but vomiting may affect absorption of oral anticoagulants.

Recommendations

  • Consult your cardiologist or OB-GYN before needing EC—have a plan.
  • Levonorgestrel 1.5 mg is preferred for most cardiac patients (OTC, well-studied).
  • Copper IUD is the most effective EC and provides ongoing contraception without hormones—ideal for many with cardiovascular disease.
  • Never delay EC due to heart condition without medical advice; pregnancy carries higher cardiovascular risk.

Shared decision-making ensures safety and reproductive autonomy.

Hypertension - Related Articles

Health Sciences © https://www.222health.com